ARCHIVES

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

This article is from The Cancer Letter archive.

Vol. 02 No. 28 | July 9, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009